sever
acut
respiratori
syndrom
sar
cov
newli
emerg
viru
caus
sar
high
mortal
rate
infect
peopl
studi
humor
respons
sarscov
evalu
nucleocapsid
n
spike
proteinsspecif
antibodi
patient
sera
western
blot
enzymelink
immunosorb
assay
elisa
recombin
n
protein
sarscov
purifi
transform
e
coli
serum
specimen
sarscovinfect
patient
convalesc
phase
analyz
western
blot
use
purifi
antigen
serial
serum
specimen
rtpcrconfirm
sar
patient
assay
elisa
use
recombin
n
protein
coat
antigen
western
blot
sar
patient
posit
n
proteinspecif
antibodi
wherea
sampl
posit
proteinspecif
antibodi
use
n
proteinbas
elisa
patient
posit
n
proteinspecif
antibodi
show
seroconvers
mean
day
onset
fever
immunoblot
use
detect
humor
immun
respons
sarscov
infect
antibodi
sarscov
n
protein
appear
earli
stage
infect
therefor
n
proteinbas
elisa
could
serv
simpl
sensit
specif
test
diagnos
sarscov
infect
outbreak
atyp
pneumonia
refer
sever
acut
respiratori
syndrom
sar
first
report
guangdong
provinc
peopl
republ
china
begin
novemb
spread
hong
kong
singapor
vietnam
canada
america
taiwan
sever
european
countri
juli
stop
epidem
affect
individu
claim
death
novel
viru
sarsassoci
coronaviru
sarscov
identifi
causal
agent
ksiazek
et
al
kuiken
et
al
peiri
et
al
coronavirus
caus
sever
diseas
mani
anim
infecti
bronchiti
viru
ibv
chicken
felin
infecti
periton
viru
fipv
cat
murin
hepat
viru
mhv
mice
transmiss
gastroenter
viru
tgev
pig
lai
holm
howev
previous
known
human
coronavirus
respons
mild
upper
respiratori
tract
ill
sever
one
lai
holm
sinc
new
sarscov
spread
effect
claim
high
casemort
rate
imper
understand
differ
sarscov
coronavirus
host
respons
import
understand
pathogenesi
establish
earli
clinic
diagnosi
sarscov
member
coronovirida
famili
positivestrand
rna
genom
encod
put
protein
includ
major
structur
protein
nucleocapsid
n
spike
membran
small
envelop
e
genom
organ
resembl
coronavirus
overal
similar
structur
protein
sarscov
coronavirus
low
among
viral
structur
protein
n
protein
appear
import
phosphoprotein
could
bind
viral
rna
form
helic
nucleocapsid
particip
viral
replic
baric
et
al
lai
holm
also
major
viral
antigen
stimul
host
immun
respons
previou
studi
anim
coronavirus
shown
antigen
peptid
n
protein
present
surfac
infect
cell
recogn
cell
boot
et
al
wege
et
al
immun
dna
vaccin
n
protein
tgev
could
elicit
antibodi
product
cell
respons
n
protein
mice
liu
et
al
also
report
n
proteinspecif
cellular
immun
respons
essenti
protect
fipv
infect
gerber
et
al
data
suggest
n
protein
coronaviru
possess
strong
antigen
may
play
import
role
induct
host
immun
respons
even
pathogenesi
sarscov
infect
spike
glycoprotein
also
sever
import
biolog
function
shown
cellular
metallopeptidas
angiotensinconvert
enzym
could
bind
domain
sarscov
protein
support
viral
replic
studi
murin
hepat
show
monoclon
antibodi
protein
could
neutral
viral
infect
proteinspecif
ctl
respons
could
detect
mice
collin
et
al
fleme
et
al
bergmann
et
al
patient
sar
antibodi
sarscov
detect
within
week
onset
diseas
immunofluoresc
assay
ifa
peiri
et
al
demonstr
convalesc
sera
patient
sar
could
react
strongli
kda
protein
deriv
supernat
sarscovinfect
vero
cell
krokhin
et
al
size
protein
equival
nucleocapsid
protein
coronavirus
littl
known
tempor
profil
antibodi
respons
n
protein
protein
sarscov
therefor
studi
serolog
respons
sarscov
n
protein
immunoblot
enzymelink
immunosorb
assay
elisa
cdna
clone
plasmid
construct
cdna
encod
sar
nucleocapsid
spike
protein
gener
revers
transcript
sar
coronaviru
access
use
superscript
ii
invitrogen
carlsbad
ca
follow
amplif
use
platinum
taq
dna
polymeras
invitrogen
oligonucleotid
primer
nucleocapsid
protein
forward
nt
revers
nt
primer
set
spike
aa
forward
nt
revers
nt
result
cdna
fragment
ligat
amersham
pharmacia
biotech
littl
chalfont
england
plasmid
recombin
protein
express
gstnucleocapsid
gstn
gstspike
gst
construct
transform
e
coli
strain
respect
singl
coloni
grown
overnight
lb
medium
contain
mgml
ampicillin
od
reach
cell
induc
mm
isopropylbdthiogalactosid
iptg
hr
cell
collect
centrifug
resuspend
tne
buffer
mm
tri
ph
nacl
mm
edta
mm
pmsf
ml
per
od
cell
cell
either
lyse
sonic
microfluid
depend
volum
cultur
centrifug
lysat
separ
supernat
pellet
fraction
solubl
recombin
protein
determin
sdspage
analysi
two
fraction
purifi
recombin
protein
lysat
incub
tneequilibr
glutathion
resin
hr
consequ
resin
pack
wash
pb
contain
triton
flow
rate
mlmin
bound
protein
elut
mm
reduc
glutathion
mm
tri
ph
buffer
purifi
recombin
n
protein
use
antibodi
gener
also
use
antigen
western
blot
elisa
purifi
protein
separ
capillari
hplc
abi
hplc
perkinelm
life
scienc
inc
boston
inlin
coupl
lcq
ion
trap
mass
spectromet
finnigan
acquir
mass
spectra
analyz
sequest
browser
correl
msm
spectrum
amino
acid
sequenc
protein
sarscov
genom
databas
cell
lysat
gammairradi
sarscovinfect
vero
noninfect
vero
cell
recombin
gstn
gst
protein
separ
sdspage
use
polyacrylamid
gel
transfer
hybond
tm
c
super
nitrocellulos
membran
amersham
pharmacia
biotech
electroblot
sambrook
russel
membran
block
hr
nonfat
dri
milk
room
temperatur
probe
heatinactiv
serum
specimen
dilut
patient
sar
convalesc
phase
rabbit
antigstn
sera
dilut
rabbit
antigst
sera
dilut
respect
hr
membran
wash
three
time
pb
contain
tween
incub
horseradish
peroxidas
hrp
conjug
sheep
antihuman
immunoglobulin
g
igg
amersham
pharmacia
biotech
hrpconjug
goat
antirabbit
immunoglobulin
ig
dako
corpor
carpinteria
detect
chemiluminesc
perkinelm
life
scienc
inc
use
kodak
biomax
mr
film
eastman
kodak
compani
new
york
one
hundr
nineti
microlit
specimen
diluent
ad
well
purifi
recombin
gstn
proteinco
plate
coat
antigen
concentr
mgml
ml
heatinactiv
test
sera
ad
mix
incub
min
plate
rins
six
time
wash
solut
ml
work
conjug
antihuman
igg
hrp
conjug
ad
incub
min
plate
rins
six
time
wash
solut
ml
tmb
solut
ad
well
plate
incub
min
room
temperatur
reaction
stop
ad
ml
stop
solut
n
h
absorb
nm
read
test
codevelop
gener
biolog
corp
hsinchu
taiwan
us
patient
serum
specimen
collect
rtpcrconfirm
sar
patient
nation
taiwan
univers
hospit
patient
seri
serum
sampl
obtain
admiss
thereaft
neg
serum
specimen
collect
healthi
blood
donor
sera
use
western
blot
analysi
patient
sar
convalesc
phase
provid
center
diseas
control
taiwan
rabbit
antigstn
antigst
sera
collect
rabbit
immun
three
time
purifi
recombin
gstn
gst
protein
respect
ltk
biolaboratori
taipei
taiwan
biosafeti
concern
patient
serum
specimen
use
elisa
western
blot
inactiv
heat
min
experi
perform
lab
obtain
individu
sarscov
antigen
initi
select
open
read
frame
spike
nucleocapsid
protein
sarscov
genom
express
recombin
protein
suitabl
primer
cover
complet
open
read
frame
strain
use
produc
correspond
cdna
insert
gst
fusion
express
vector
protein
express
hsueh
et
al
yeh
et
al
gst
fusion
protein
gstn
gst
express
strain
respect
lyse
separ
pellet
supernat
fraction
although
pellet
fraction
contain
residu
recombin
n
protein
signific
portion
recombin
protein
found
solubl
fraction
data
shown
could
recov
gstn
gst
fusion
protein
reduc
glutathion
agaros
chromatographi
fig
lane
result
recombin
protein
size
kda
gstn
kda
gst
purifi
protein
use
antigen
western
blot
elisa
ident
purifi
recombin
protein
confirm
iontrac
mass
spectrometri
figur
show
typic
result
mass
spectrometri
determin
antigen
n
protein
natur
sarscov
infect
sera
patient
convalesc
phase
react
cell
lysat
sarscovinfect
vero
noninfect
vero
cell
recombin
gstn
protein
immunoblot
patient
sera
dilut
consist
react
protein
approxim
kda
cell
lysat
sarscovinfect
vero
cell
fig
lane
well
recombin
gstn
protein
kda
immunoblot
fig
lane
wherea
none
neg
sera
reactiv
dilut
data
shown
one
three
sera
show
reactiv
protein
approxim
kda
cell
lysat
sarscovinfect
vero
fig
lane
well
recombin
gst
protein
kda
fig
lane
also
immun
rabbit
recombin
gstn
gst
protein
respect
produc
rabbit
antin
anti
antibodi
three
time
immun
sera
immun
rabbit
collect
assay
reactiv
sarscovinfect
vero
cell
lysat
recombin
gstn
gst
protein
immunoblot
immun
sera
dilut
react
protein
approxim
kda
cell
lysat
sarscovinfect
vero
recombin
gstn
protein
fig
lane
immun
sera
gst
immun
rabbit
could
react
protein
kda
cell
lysat
sarscovinfect
vero
cell
recombin
gst
protein
kda
dilut
fig
lane
result
indic
recombin
gstn
recombin
gst
protein
could
react
specif
antibodi
patient
sera
antigen
similar
nativ
form
cell
lysat
sarscovinfect
vero
cell
character
serolog
respons
n
protein
sarscov
infect
test
serum
specimen
sarscovposit
patient
western
blot
recombin
gstn
gst
protein
result
sarscovposit
sampl
sarscovneg
sampl
healthi
blood
donor
shown
figur
nineteen
sarscovposit
sampl
dilut
show
signific
reactiv
recombin
gst
protein
fig
lane
thirtynin
posit
sera
dilut
consist
react
gstn
protein
immunoblot
fig
lane
addit
sampl
show
strong
reactiv
gstn
protein
one
posit
sera
show
reactiv
recombin
gstn
protein
also
show
reactiv
recombin
gst
protein
data
shown
five
sarscovneg
sampl
show
reactiv
gstn
gst
protein
fig
lane
data
impli
titer
posit
rate
antibodi
n
protein
much
higher
protein
sarscov
infect
therefor
use
n
protein
coat
antigen
elisa
detect
sarscov
infect
cooper
gener
biolog
corp
develop
n
proteinbas
elisa
first
perform
checkerboard
titrat
antigen
coat
microwel
plate
use
mgml
mgml
mgml
mg
ml
antigen
respect
absorb
nm
control
sera
increas
coat
antigen
use
therefor
use
mgml
antigen
coat
plate
mean
normal
control
sera
nprotein
elisa
quit
low
dilut
sera
n
fig
number
normal
control
sera
expand
mean
aestandard
deviat
sd
dilut
mean
sd
set
cutoff
valu
fals
posit
rate
neg
sera
use
cutoff
valu
elisa
perform
serial
dilut
posit
sera
produc
typic
elisa
curv
end
point
dilut
fig
howev
obviou
variat
titer
n
proteinspecif
antibodi
differ
patient
sera
note
reflect
huge
error
bar
sinc
posit
neg
sera
gave
distinct
result
dilut
use
dilut
assay
serial
serum
specimen
collect
twelv
pcrconfirm
sar
patient
fig
serum
sampl
patient
posit
n
proteinspecif
igg
fig
c
shown
figur
igg
seroconvers
n
protein
shown
six
patient
mean
day
four
patient
whose
n
proteinspecif
igg
posit
first
serum
specimen
patient
may
due
later
serum
collect
onset
fever
case
patient
fig
unknown
reason
first
serum
specimen
patient
posit
n
proteinspecif
antibodi
although
collect
day
onset
fever
fig
patient
high
titer
n
proteinspecif
antibodi
sar
patient
could
last
day
infect
fig
n
proteinspecif
igg
undetect
serial
serum
specimen
patient
patient
fig
may
due
low
titer
antibodi
serum
specimen
accord
figur
ascend
serum
sampl
four
patient
impli
titer
n
proteinspecif
igg
increas
onset
sar
data
clearli
demonstr
n
protein
sarscov
antigen
natur
cours
infect
antibodi
n
protein
detect
consist
among
sera
patient
sar
convalesc
phase
furthermor
recombin
n
protein
express
e
coli
antigen
similar
nativ
one
importantli
recombin
n
proteinbas
elisa
effect
detect
specif
antibodi
sera
patient
sar
serial
serum
specimen
show
seroconvers
increas
antibodi
titer
n
protein
data
similar
obtain
sarscovbas
elisa
ifa
peiri
et
al
still
satisfactori
diagnost
method
sarscov
infect
realtim
polymeras
chain
reaction
rtpcr
sarscovbas
elisa
ifa
three
commonli
use
method
detect
either
viral
rna
viru
specif
antibodi
rtpcr
techniqu
rel
sensit
assay
compar
other
could
detect
low
copi
sarscov
viral
transcript
per
reaction
correspond
rna
molecul
per
millilit
specimen
howev
fals
posit
rate
may
higher
method
crosscontamin
laboratori
serolog
examin
provid
anoth
independ
evid
infect
sarscovbas
elisa
ifa
need
prepar
virus
sourc
antigen
may
reduc
access
gener
laboratori
without
biosafti
contain
facil
n
proteinbas
elisa
perform
laboratori
without
contain
facil
due
use
singl
immunogen
viral
protein
instead
highli
infecti
sarscov
coat
antigen
contrast
ifa
suitabl
largescal
survey
elisa
base
recombin
protein
coat
antigen
easier
produc
perform
serum
sampl
patient
neg
n
proteinspecif
antibodi
fig
serum
specimen
patient
assay
ifa
antibodi
also
undetect
dilut
data
shown
may
due
antibodi
titer
patient
high
enough
detect
elisa
ifa
day
onset
fever
patient
immunocompromis
may
explain
antibodi
n
protein
remain
cutoff
valu
day
onset
fever
accord
data
antibodi
protein
could
detect
sera
sarscovinfect
individu
although
alreadi
produc
antin
protein
antibodi
may
due
use
truncat
spike
protein
cover
major
antigen
ntermin
recogn
antibodi
gener
sarscovinfect
patient
found
pig
upon
tgev
infect
order
achiev
protect
immun
respons
equival
induc
full
protein
intact
globular
ntermin
half
protein
essenti
tuboli
et
al
globular
ntermin
part
sarscov
protein
almost
includ
gst
construct
therefor
need
studi
elucid
whether
sarscov
globular
nterminalspikespecif
antibodi
gener
sar
patient
n
protein
prove
abund
protein
found
purifi
sarscov
virion
rota
et
al
fig
n
proteinbas
elisa
antihuman
igg
mab
hrp
conjug
presenc
n
proteinspecif
igg
sera
sar
patient
detect
elisa
twofold
serial
dilut
known
posit
serum
specimen
n
test
plate
coat
recombin
gstn
protein
serum
specimen
healthi
blood
donor
n
use
neg
control
result
express
mean
standard
error
b
serum
sampl
seven
pcrconfirm
sar
patient
assay
first
serum
specimen
seven
sar
patient
collect
within
week
onset
fever
c
serum
sampl
three
pcrconfirm
sar
patient
assay
patient
repres
group
whose
first
serum
specimen
collect
day
onset
fever
serum
sampl
two
pcrconfirm
sar
patient
assay
group
repres
nonrespond
show
seroconvers
sarscov
infect
lot
exampl
show
coronaviru
infect
immun
respons
n
protein
could
gener
n
protein
mhv
could
elicit
cell
respons
contribut
protect
coronavirusinduc
encephalomyel
stohlman
et
al
wege
et
al
chicken
prime
recombin
nucleocapsid
protein
ibv
show
increas
tracheal
protect
challeng
live
ibv
boot
et
al
increas
antibodi
titer
nucleocapsid
protein
human
coronaviru
could
detect
pair
sera
volunt
experiment
infect
human
coronaviru
group
virus
macnaughton
et
al
evid
impli
larg
amount
n
protein
may
produc
infect
cell
antigen
n
protein
strong
vivo
consist
found
n
protein
could
elicit
strong
immun
respons
antibodi
product
earli
stage
sar
infect
studi
need
understand
whether
immun
respons
n
protein
associ
pathogenesi
sarscov
sarscov
newli
emerg
viru
still
avail
reliabl
method
detect
n
proteinspecif
antibodi
therefor
hard
evalu
sensit
n
proteinbas
elisa
sinc
fals
posit
rate
nprotein
base
elisa
among
healthi
blood
donor
specif
elisa
report
antibodi
human
coronavirus
widespread
human
popul
mcintosh
et
al
bradburn
somerset
accord
observ
serolog
reactiv
sarscov
among
healthi
blood
donor
patient
respiratori
diseas
hong
kong
peiri
et
al
suggest
cross
reactiv
antibodi
previous
known
coronavirus
sarscov
still
need
studi
elucid
whether
fals
posit
case
caus
crossreact
antibodi
preexist
human
coronavirus
recombin
n
protein
sarscov
also
suggest
use
immunoblot
confirm
fals
posit
sampl
case
detect
antihiv
antihtlv
antibodi
conclus
n
proteinbas
elisa
use
recombin
proteinbas
elisa
detect
antibodi
sarscov
could
serv
simpl
sensit
specif
test
conduct
largescal
seroepidemiolog
studi
help
understand
sarscov
epidem
